44.192.79.149
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-

Cornea and External Disease

Study finds TTHX1114 enhances visual recovery, corneal deturgescence after DSO

TTHX1114, an engineered FGF1, when administered in a dose-responsive manner, can enhance the rate of visual recovery and corneal deturgescence following Descemet stripping only (DSO), according to data presented at ASCRS 2023. Smaller descemetorhexis was associated with a faster recovery, while the presence of comorbid diabetes appeared to delay recovery....

Read More
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
Click to access the login or register cheese